We wish to inform that the Board of Directors in their meeting held today, i.e., March 27, 2025, inter-alia, considered and approved the following items:1. Allotment of 25,00,00,000 (Twenty-Five Crore Only) equity share warrants to non-promoters on Preferential Basis at an issue price of Rs. 1.68/- (Rupees one and sixty-eight paise) each upon receipt of other 5% of the total consideration.The above said allotments have been made in accordance with the terms mentioned in the notice of Postal Ballot dated 13.08.2024 and in compliance with the applicable provisions of the Companies Act, 2013 and SEBI (ICDR) Regulations.Disclosures pursuant to the Regulation 30 of the SEBI (LODR) Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached as Annexure A. The meeting commenced at 05:00 P.M. and concluded at 05:40 P.M.This is for your information.Thanking You.
Biogen Pharmachem Industries Limited Press Release Mar 27 2025
Filed with BSE · · 2 pages · English
Release
Biogen Pharmachem Industries Limited on 6ix
Earlier from Biogen Pharmachem Industries
- Biogen Pharmachem Industries Limited Press Release Mar 21 2025
- Biogen Pharmachem Industries Limited Press Release Mar 11 2025
- Biogen Pharmachem Industries Limited Press Release Mar 08 2025
- Biogen Pharmachem Industries Limited Press Release Mar 07 2025
- Biogen Pharmachem Industries Limited Press Release Feb 05 2025
Later from Biogen Pharmachem Industries
- Biogen Pharmachem Industries Limited Press Release Apr 08 2025
- Biogen Pharmachem Industries Limited Press Release Apr 15 2025
- Biogen Pharmachem Industries Limited Press Release May 08 2025
- Biogen Pharmachem Industries Limited Press Release May 12 2025
- Biogen Pharmachem Industries Limited Press Release May 23 2025
Follow Biogen Pharmachem Industries into a list and get an email when it puts out news.
Follow Biogen Pharmachem Industries